Evidence map›Paper›PMID 39975307›Full record

ArticlebioRxiv : the preprint server for biology2025

All-

Mariia Dvoriashyna, Melissa Bentley-Ford, Jianshi Yu, Saptarshi Chatterjee, Machelle T Pardue, Maureen A Kane, Rodolfo Repetto, C Ross Ethier

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Updated by
    All2025
5 · Who and what money

Authors and funding

8 authors.

Mariia DvoriashynaSchool of Mathematics and Maxwell Institute for Mathematical Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-6057-1919
Melissa Bentley-FordDepartment of Ophthalmology, Emory University School of Medicine, Atlanta, GA, USA.
Jianshi YuDepartment of Pharmaceutical Sciences, University of Maryland, Baltimore, MD, 21201, USA.
Saptarshi ChatterjeeWallace H. Coulter Dept. of Biomedical Engineering, Georgia Institute of Technology & Emory University, Atlanta, GA, 30332, USA.ORCID 0000-0002-3334-1691
Machelle T PardueDepartment of Ophthalmology, Emory University School of Medicine, Atlanta, GA, USA.
Maureen A KaneDepartment of Pharmaceutical Sciences, University of Maryland, Baltimore, MD, 21201, USA.
Rodolfo RepettoDepartment of Civil, Chemical and Environmental Engineering, University of Genoa, Genoa, Italy.
C Ross EthierDepartment of Ophthalmology, Emory University School of Medicine, Atlanta, GA, USA.ORCID 0000-0001-6110-3052

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 1986 to 2025
$15.3M
Retinal Mechanisms of Refractive DevelopmentR01EY016435 · NEI · GEORGIA INSTITUTE OF TECHNOLOGY · PI Machelle T. Pardue · 2009 to 2026
$5.4M
VIsion Science Training in AtlantaT32EY007092 · NEI · EMORY UNIVERSITY · PI Machelle T. Pardue · 1985 to 2026
$4.6M
Mechanisms of axial elongation in myopiaR01EY033361 · NEI · GEORGIA INSTITUTE OF TECHNOLOGY · PI C ROSS ETHIER, MAUREEN A KANE · 2022 to 2026
$2.9M
Investigating the role of scleral fibroblasts in refractive development and myopiaF32EY035573 · NEI · EMORY UNIVERSITY · PI BENTLEY, MELISSA R · 2024 to 2024
$74k
NEI NIH HHS F32 EY035573NEI NIH HHS P30 EY006360NEI NIH HHS R01 EY016435NEI NIH HHS R01 EY033361NEI NIH HHS T32 EY007092RRD VA IK6 RX003134
6 · The paper itself

Abstract

Myopia, or near-sightedness, is rapidly growing in prevalence, with significant long-term implications for ocular health. There is thus great impetus to better understand molecular signaling pathways leading to myopia. We and others have reported that all-trans retinoic acid (atRA) is involved in myopigenic signaling, yet the understanding of how atRA is transported and exerts a myopigenic influence is poor. Here we measured the concentrations of atRA in the serum in wild-type C57BL/6 mice under control conditions and after atRA feeding, previously shown to induce myopia. We also developed a mathematical model that describes fluid fluxes and the advective-diffusive transport of atRA in choroid and sclera, including atRA synthesis in the choriocapillaris, atRA degradation by scleral cells, and binding of atRA to the carrier protein serum albumin. This model, developed for both mice and humans, showed that atRA produced in the choriocapillaris was able to permeate well into the sclera in both mice and humans at biologically-relevant concentrations, and that atRA feeding greatly increased tissue levels of atRA across both the choroid and sclera. We were also able to identify which parameters most influence atRA concentration in ocular tissues, guiding future experimental work. Our findings support atRA's role in myopigenic signaling.

Indexed as

all-trans retinoic acidmathematical modellingmyopiaunconventional outflow

Identifiers

PMID39975307
PMCPMC11839105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.